Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://amiegpno385739.designertoblog.com/70155452/retaglutide-a-promising-glp-1-receptor-agonist